Bruker Posts 35 Percent Q3 Revenue Growth, Misses EPS Estimate | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker today reported a 35 percent increase in third-quarter revenues but fell short of analyst EPS estimates by a penny.

For the three months ended Sept. 30, the firm said it had $418.4 million in revenues, up from $310.2 million a year ago and ahead of Wall Street expectations of $393.2 million. Organically revenues were up 11 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

Craig Venter's Health Nucleus aims to change preventive medicine, according to the Robb Report.